
  
    
      
        Introduction_NNP
        Sickle_NNP cell_NN disease_NN (_( SCD_NNP )_) is_VBZ the_DT most_RBS common_JJ genetic_JJ
        disorder_NN in_IN African_JJ and_CC African_NNP American_JJ populations_NNS and_CC it_PRP
        is_VBZ associated_VBN with_IN increased_VBN morbidity_NN and_CC mortality_NN in_IN
        affected_VBN individuals_NNS [_NN 1_CD ]_NN ._. Children_NNP with_IN SCD_NNP exhibit_NN
        impaired_VBN growth_NN [_NN 2_CD 3_CD 4_CD ]_NN as_RB well_RB as_IN delayed_VBN skeletal_NN and_CC
        sexual_JJ maturation_NN [_NN 5_CD ]_NN ._. The_DT underlying_VBG cause_NN of_IN growth_NN
        retardation_NN in_IN SCD_NNP has_VBZ not_RB been_VBN confirmed_VBN but_CC has_VBZ been_VBN
        attributed_VBN to_TO several_JJ factors_NNS such_JJ as_IN increased_VBN resting_VBG
        metabolic_JJ rate_NN [_NN 6_CD ]_NN and_CC deficiencies_NNS of_IN various_JJ nutrient_NN
        including_VBG folate_NN ,_, zinc_NN ,_, vitamin_NN A_DT ,_, vitamin_NN E_NNP and_CC iron_NN [_NN 7_CD ]_NN
        ._.
        In_IN a_DT previous_JJ study_NN of_IN the_DT fatty_NN acid_NN composition_NN of_IN the_DT
        serum_NN phospholipids_NNS of_IN children_NNS with_IN SCD_NNP and_CC healthy_JJ
        controls_NNS that_IN we_PRP conducted_VBD in_IN Nigeria_NNP [_NN 8_CD ]_NN ,_, we_PRP found_VBD that_IN
        the_DT serum_NN phospholipids_NNS of_IN SCD_NNP patients_NNS and_CC controls_NNS had_VBD
        comparable_JJ levels_NNS of_IN linoleic_JJ and_CC α-linolenic_JJ acid_NN ._.
        However_RB ,_, the_DT percentages_NNS of_IN the_DT long-chain_JJ polyunsaturated_JJ
        fatty_NN acids_NNS derived_VBN from_IN these_DT two_CD essential_JJ fatty_NN acids_NNS
        were_VBD significantly_RB decreased_VBN whereas_IN the_DT proportions_NNS of_IN
        saturated_VBD fatty_NN acids_NNS ,_, namely_RB oleic_JJ acid_NN and_CC palmitic_JJ acid_NN ,_,
        were_VBD significantly_RB increased_VBN ._. Similar_JJ alterations_NNS in_IN the_DT
        serum_NN total_JJ phospholipid_NN composition_NN of_IN children_NNS with_IN SCD_NNP
        have_VBP been_VBN reported_VBN by_IN others_NNS [_NN 9_CD ]_NN ._.
        The_DT fatty_NN acid_NN composition_NN of_IN serum_NN phospholipids_NNS is_VBZ
        known_VBN to_TO reflect_VB the_DT phospholipid_NN composition_NN of_IN cell_NN
        membranes_NNS [_NN 10_CD ]_NN ._. Because_IN the_DT fatty_NN acid_NN composition_NN of_IN
        membrane_NN phospholipids_NNS is_VBZ a_DT major_JJ determinant_NN of_IN membrane_NN
        fluidity_NN and_CC function_NN [_NN 11_CD ]_NN ,_, any_DT alteration_NN in_IN fatty_NN acid_NN
        composition_NN of_IN membrane_NN phospholipids_NNS could_MD contribute_VB to_TO
        the_DT red_JJ cell_NN abnormalities_NNS seen_VBN in_IN SCD_NNP ,_, such_JJ as_IN cation_NN
        imbalance_NN ,_, dehydration_NN ,_, reduced_VBN deformability_NN and_CC
        hypercoagulability_NN [_NN 12_CD 13_CD ]_NN ._.
        Phase_NN angle_NN is_VBZ a_DT bioelectrical_JJ impedance_NN parameter_NN
        derived_VBN from_IN the_DT measured_VBN impedance_NN parameters_NNS ,_, resistance_NN
        (_( R_NN )_) and_CC reactance_NN (_( Xc_NNP )_) ._. Whereas_IN R_NN is_VBZ related_VBN to_TO the_DT
        magnitude_NN of_IN the_DT lean_JJ body_NN mass_NN ,_, Xc_NNP reflects_VBZ the_DT
        capacitance_NN produced_VBN by_IN cell_NN membranes_NNS and_CC tissue_NN
        interfaces_NNS ._. This_DT capacitance_NN causes_VBZ the_DT current_NN to_TO lag_VB the_DT
        voltage_NN ,_, creating_VBG a_DT phase_NN shift_NN ._. Phase_NN angle_NN is_VBZ regarded_VBN as_IN
        an_DT indicator_NN of_IN cellular_JJ health_NN and_CC membrane_NN integrity_NN ,_, a_DT
        low_JJ phase_NN angle_NN being_VBG indicative_JJ of_IN a_DT deterioration_NN in_IN the_DT
        integrity_NN or_CC function_NN of_IN cell_NN membranes_NNS ._. Phase_NN angle_NN has_VBZ
        been_VBN shown_VBN to_TO be_VB a_DT reliable_JJ predictor_NN of_IN outcome_NN in_IN a_DT
        variety_NN of_IN clinical_JJ conditions_NNS where_WRB alterations_NNS in_IN cell_NN
        membranes_NNS are_VBP known_VBN to_TO occur_VB ,_, including_VBG sepsis_NN [_NN 14_CD ]_NN ,_,
        trauma_NN [_NN 15_CD ]_NN ,_, HIV_NNP infection_NN [_NN 16_CD ]_NN and_CC cancer_NN [_NN 17_CD ]_NN
        ._.
        In_IN a_DT recent_JJ study_NN of_IN Nigerian_NNP children_NNS with_IN SCD_NNP ,_, we_PRP
        determined_VBD the_DT fatty_NN acid_NN composition_NN of_IN serum_NN
        phospholipids_NNS and_CC correlated_JJ fatty_NN acid_NN proportions_NNS with_IN
        the_DT phase_NN angle_NN [_NN 18_CD ]_NN ._. The_DT percentage_NN of_IN palmitic_JJ acid_NN
        and_CC oleic_JJ acid_NN correlated_JJ inversely_RB with_IN phase_NN angle_NN ,_,
        whereas_IN ,_, in_IN contrast_NN ,_, three_CD polyunsaturated_JJ fatty_NN acids_NNS of_IN
        the_DT n-_NN 3_CD series_NN (_( eicosapentaenoic_JJ ,_, 20_CD :_: 5_CD n-_NN 3_CD ;_:
        docosapentaenoic_JJ ,_, 22_CD :_: 5_CD n-_NN 3_CD ;_: and_CC docosahexaenoic_JJ ,_, 22_CD :_: 6_CD n-_NN 3_LS )_)
        were_VBD positively_RB correlated_JJ with_IN phase_NN angle_NN ._. If_IN serum_NN
        phospholipids_NNS are_VBP truly_RB surrogates_NNS for_IN membrane_NN
        phospholipids_NNS ,_, as_IN is_VBZ widely_RB believed_VBN ,_, then_RB the_DT correlations_NNS
        we_PRP observed_VBD between_IN specific_JJ fatty_NN acids_NNS and_CC phase_NN angle_NN
        should_MD apply_VB to_TO the_DT fatty_NN acids_NNS of_IN tissue_NN membrane_NN
        phospholipids_NNS as_RB well_RB ._.
        Cholesterol_NNP and_CC phospholipids_NNS are_VBP the_DT major_JJ lipid_NN
        components_NNS of_IN cell_NN membranes_NNS and_CC the_DT major_JJ determinants_NNS of_IN
        membrane_NN fluidity_NN and_CC function_NN [_NN 11_CD ]_NN ._. In_IN the_DT present_JJ
        study_NN ,_, using_VBG the_DT cholesterol_NN content_NN and_CC the_DT fatty_NN acid_NN
        composition_NN of_IN red_JJ cell_NN membranes_NNS as_IN surrogates_NNS for_IN tissue_NN
        membranes_NNS in_IN children_NNS with_IN SCD_NNP and_CC healthy_JJ controls_NNS ,_, we_PRP
        found_VBD significant_JJ correlations_NNS between_IN phase_NN angle_NN with_IN
        both_DT cholesterol_NN and_CC the_DT proportions_NNS of_IN specific_JJ n-_NN 3_CD
        polyunsaturated_JJ fatty_NN acids_NNS in_IN the_DT red_JJ cell_NN phospholipids_NNS
        of_IN these_DT subjects_NNS ._.
      
      
        Methods_NNP
        
          Sample_NNP collection_NN
          Blood_NNP was_VBD obtained_VBN by_IN venipuncture_NN and_CC collected_VBN into_IN
          vacutainer_NN tubes_NNS containing_VBG EDTA_NNP as_IN the_DT anticoagulant_NN ._.
          After_IN centrifugation_NN at_IN 5_CD ,_, 000_CD ×_NN g_SYM for_IN 10_CD min_NN ,_, the_DT plasma_NN
          fraction_NN was_VBD removed_VBN ._. The_DT red_JJ blood_NN cells_NNS were_VBD washed_VBN
          twice_RB with_IN 0_CD ._. 9_CD %_NN (_( w_NN /_NN v_NN )_) NaCl_NNP to_TO remove_VB plasma_NN ,_, platelets_NNS
          and_CC leukocytes_NNS and_CC then_RB resuspended_JJ in_IN saline_NN ._. The_DT red_JJ
          blood_NN cell_NN suspension_NN was_VBD then_RB aliquoted_JJ into_IN cryovials_NNS
          and_CC frozen_VBN at_IN -_: 40_CD °_NN C_NNP until_IN transported_VBN in_IN the_DT frozen_VBN state_NN
          to_TO the_DT University_NNP of_IN New_NNP Mexico_NNP School_NNP of_IN Medicine_NNP for_IN
          analysis_NN ._.
        
        
          Fatty_NNP acid_NN analysis_NN of_IN red_JJ cell_NN
          phospholipids_NNS
          Briefly_NNP ,_, the_DT total_JJ lipids_NNS in_IN 0_CD ._. 15_CD ml_NN of_IN red_JJ blood_NN
          cells_NNS were_VBD extracted_VBN into_IN chloroform_NN :_: methanol_NN (_( 1_CD :_: 1_CD ,_,
          v_NN /_NN v_NN )_) ._. The_DT extract_NN was_VBD evaporated_VBN under_IN a_DT stream_NN of_IN
          nitrogen_NN ,_, redissolved_JJ in_IN 0_CD ._. 5_CD ml_NN chloroform_NN ,_, and_CC loaded_VBD
          onto_IN a_DT silicic_JJ acid_NN column_NN which_WDT had_VBD previously_RB been_VBN
          prepared_VBN and_CC washed_VBN with_IN chloroform_NN ._. Neutral_NNP lipids_NNS were_VBD
          eluted_JJ with_IN 5_CD ml_NN chloroform_NN ._. Total_JJ phospholipids_NNS were_VBD
          eluted_JJ with_IN 6_CD ml_NN chloroform_NN :_: methanol_NN (_( 2_CD :_: 1_CD ,_, v_NN /_NN v_NN )_) ._. The_DT
          eluate_NN was_VBD again_RB dried_VBN under_IN a_DT stream_NN of_IN nitrogen_NN and_CC
          redissolved_JJ in_IN 0_CD ._. 5_CD ml_NN 15_CD %_NN (_( w_NN /_NN v_NN )_) BF_NNP 
          3_CD in_IN methanol_NN ._. Preparation_NNP of_IN fatty_NN
          acid_NN methyl_NN esters_NNS was_VBD carried_VBN out_IN as_RB previously_RB
          described_VBN by_IN Morrison_NNP and_CC Smith_NNP [_NN 19_CD ]_NN ._. The_DT methylation_NN
          reaction_NN was_VBD carried_VBN out_RB at_IN 100_CD °_NN C_NNP for_IN 10_CD min_NN ._. Fatty_NNP acid_NN
          methyl_NN esters_NNS were_VBD quantitated_JJ using_VBG a_DT 0_CD ._. 53_CD mm_NN ×_NN 15_CD m_NN
          fused_JJ silica_NN Megabore_NNP DB-_NNP 225_CD column_NN (_( J_NNP &_CC W_NNP ,_, Folsom_NNP ,_,
          CA_NNP )_) in_IN a_DT gas_NN chromatograph_NN (_( Hewlett_NNP Packard_NNP ,_, model_NN 5890_CD )_)
          equipped_VBN with_IN an_DT integrator_NN ._. Fatty_NNP acids_NNS were_VBD identified_VBN
          by_IN comparison_NN of_IN their_PRP$ retention_NN times_NNS to_TO those_DT of_IN fatty_NN
          acid_NN standards_NNS (_( Supelco_NNP ,_, Inc_NNP ._. ,_, Bellefonte_NNP ,_, PA_NNP )_) and_CC
          results_NNS were_VBD expressed_VBN as_IN weight_NN percent_NN of_IN total_JJ fatty_NN
          acids_NNS ._.
        
        
          Cholesterol_NNP analysis_NN of_IN red_JJ cell_NN membrane_NN
          Cholesterol_NNP was_VBD extracted_VBN from_IN the_DT red_JJ cell_NN suspension_NN
          as_IN follows_VBZ ._. One_CD ml_NN of_IN red_JJ cell_NN suspension_NN was_VBD extracted_VBN
          with_IN 30_CD ml_NN of_IN chloroform_NN /_NN methanol_NN (_( 2_CD ;_: 1_CD ,_, v_NN /_NN v_NN )_) and_CC the_DT
          total_JJ lipids_NNS reconstituted_JJ in_IN 0_CD ._. 5_CD ml_NN chloroform_NN ._. To_TO a_DT 200_CD
          μl_NN aliquot_NN of_IN the_DT total_JJ lipid_NN extract_NN 1_CD ml_NN ethanol_NN and_CC
          300_CD μl_NN potassium_NN hydroxide_NN solution_NN (_( 30_CD %_NN by_IN weight_NN )_) were_VBD
          added_VBN ._. The_DT mixture_NN also_RB contained_VBD 107_CD μg_NN of_IN
          5_CD -_: α-cholestane_JJ (_( internal_JJ standard_JJ )_) ._. The_DT mixture_NN was_VBD
          heated_JJ at_IN 80_CD °_NN C_NNP for_IN 20_CD minutes_NNS ._. Following_VBG saponification_NN ,_,
          1_CD ml_NN water_NN and_CC 2_CD ml_NN hexane_NN were_VBD added_VBN to_TO the_DT mixture_NN ._.
          After_IN mixing_VBG and_CC centrifugation_NN ,_, the_DT upper_JJ hexane_NN layer_NN
          was_VBD removed_VBN and_CC transferred_VBN to_TO a_DT clean_JJ test_NN tube_NN and_CC the_DT
          aqueous_JJ layer_NN was_VBD extracted_VBN twice_RB more_JJR with_IN 1_CD ._. 5_CD ml_NN
          hexane_NN ._. The_DT combined_VBN hexane_NN layers_NNS were_VBD evaporated_VBN to_TO
          dryness_NN under_IN a_DT stream_NN of_IN nitrogen_NN and_CC the_DT extracted_VBN
          cholesterol_NN was_VBD dissolved_VBN in_IN hexane_NN for_IN gas_NN
          chromatographic_JJ analysis_NN ._.
          Cholesterol_NNP was_VBD analyzed_VBN using_VBG a_DT Hewlett-_NNP Packard_NNP gas_NN
          liquid_JJ chromatograph_NN (_( model_NN 5890_CD )_) equipped_VBN with_IN a_DT flame_NN
          ionization_NN detector_NN and_CC a_DT fused-silica_JJ capillary_JJ column_NN
          (_( SAC-_NNP 5_CD ,_, 30_CD m_NN ×_NN 0_CD ._. 25_CD mm_NN ,_, Supelco_NNP ,_, Bellefonte_NNP ,_, PA_NNP )_) and_CC
          helium_NN carrier_NN gas_NN ._. The_DT injector_NN and_CC detector_NN temperature_NN
          were_VBD at_IN 300_CD °_NN C_NNP ._. The_DT initial_JJ column_NN temperature_NN of_IN 285_CD °_NN C_NNP
          was_VBD maintained_VBN for_IN 15_CD min_NN and_CC then_RB increased_VBN to_TO 290_CD °_NN C_NNP
          over_IN 5_CD min_NN and_CC held_VBN at_IN 290_CD °_NN C_NNP for_IN 5_CD min_NN ._. Cholesterol_NNP
          content_NN was_VBD expressed_VBN as_IN mg_NN /_NN ml_NN red_JJ cell_NN suspension_NN volume_NN
          and_CC then_RB normalized_JJ to_TO phosphorus_JJ ._.
        
        
          Determination_NNP of_IN red_JJ cell_NN phosphorus_JJ
          All_DT glassware_NN used_VBN for_IN phosphorus_JJ analysis_NN was_VBD rinsed_JJ
          with_IN hydrochloric_JJ acid_NN and_CC deionized_JJ water_NN ._. One_CD ml_NN of_IN
          washed_VBN red_JJ blood_NN cells_NNS was_VBD extracted_VBN with_IN 20_CD ml_NN of_IN
          chloroform_NN :_: methanol_NN (_( 2_CD :_: 1_CD ,_, v_NN /_NN v_NN )_) for_IN one_CD hour_NN at_IN room_NN
          temperature_NN ._. After_IN addition_NN of_IN 4_CD ml_NN of_IN saline_NN solution_NN ,_,
          the_DT mixture_NN was_VBD vortexed_JJ and_CC centrifuged_JJ at_IN 1_CD ,_, 000_CD rpm_NN for_IN
          5_CD min_NN to_TO obtain_VB two_CD phases_NNS ._. The_DT chloroform_NN layer_NN was_VBD
          filtered_VBN and_CC then_RB evaporated_VBD under_IN a_DT stream_NN of_IN
          nitrogen_NN ._.
          Concentrated_NNP sulfuric_JJ acid_NN (_( 0_CD ._. 5_LS ml_NN )_) was_VBD added_VBN to_TO the_DT
          tubes_NNS containing_VBG the_DT extracted_VBN phospholipids_NNS and_CC the_DT
          samples_NNS were_VBD heated_JJ in_IN a_DT sand_NN bath_NN for_IN 3_CD hours_NNS at_IN 250_CD °_NN C_NNP ._.
          After_IN the_DT addition_NN of_IN perchloric_JJ acid_NN (_( 0_CD ._. 15_CD ml_NN ,_, 70_CD %_NN )_) ,_, the_DT
          samples_NNS were_VBD heated_JJ at_IN 250_CD °_NN C_NNP for_IN an_DT additional_JJ 30_CD min_NN ,_,
          mixing_VBG occasionally_RB ._. After_IN cooling_VBG ,_, 9_CD ._. 1_CD ml_NN of_IN an_DT aqueous_JJ
          ammonium_NN molybdate_NN solution_NN (_( 26_CD %_NN by_IN weight_NN )_) and_CC 0_CD ._. 4_CD ml_NN of_IN
          Fiske-_NNP Subbarow_NNP reagent_NN were_VBD added_VBN and_CC the_DT samples_NNS were_VBD
          then_RB placed_VBN in_IN a_DT boiling_VBG water_NN bath_NN for_IN 10_CD min_NN ._. The_DT
          absorbance_NN at_IN 820_CD nm_NN was_VBD measured_VBN and_CC the_DT phosphorus_JJ
          concentration_NN determined_VBD using_VBG a_DT phosphorus_JJ standard_JJ
          curve_NN constructed_VBN using_VBG disodium_NN hydrogen_NN phosphate_NN
          (_( equivalent_JJ to_TO 0_CD ._. 5_CD to_TO 20_CD ._. 0_CD μg_NN of_IN phosphorus_JJ )_) ._.
        
        
          Bioelectrical_NNP impedance_NN analysis_NN
          Impedance_NNP analysis_NN was_VBD performed_VBN using_VBG a_DT BIA-Quantum_NNP
          impedance_NN analyzer_NN (_( RJL_NNP Inc_NNP ,_, Clinton_NNP Township_NNP ,_, MI_NNP )_) ._. The_DT
          instrument_NN delivers_VBZ an_DT alternating_VBG 800_CD μamp_NN current_JJ at_IN a_DT
          frequency_NN of_IN 50_CD kHz_NN ._. Subjects_NNP were_VBD requested_VBN to_TO void_VB
          before_IN measurements_NNS were_VBD made_VBN ._. The_DT subjects_NNS laid_VBN in_IN the_DT
          supine_NN position_NN on_IN a_DT nonconducting_VBG surface_NN with_IN limbs_NNS
          abducted_NN approximately_RB 30_CD °_NN from_IN the_DT body_NN ._.
          Signal-introducing_NNP electrodes_NNS were_VBD placed_VBN on_IN the_DT first_JJ
          joint_NN of_IN the_DT middle_JJ finger_NN and_CC just_RB below_IN the_DT middle_JJ toe_NN ._.
          The_DT detecting_VBG electrodes_NNS were_VBD placed_VBN with_IN the_DT upper_JJ edge_NN
          of_IN the_DT electrode_NN bisecting_VBG the_DT ulnar_NN head_NN of_IN the_DT wrist_NN
          and_CC the_DT median_JJ malleolus_JJ of_IN the_DT foot_NN ._. Care_NNP was_VBD taken_VBN to_TO
          ensure_VB that_IN the_DT signal_NN and_CC detecting_VBG electrodes_NNS were_VBD not_RB
          closer_JJR than_IN 5_CD cm_NN ._. Duplicate_NNP measurements_NNS of_IN resistance_NN
          (_( R_NN )_) and_CC reactance_NN (_( X_NNP 
          c_SYM )_) were_VBD made_VBN on_IN each_DT subject_NN ._. Phase_NN
          angle_NN was_VBD calculated_VBN as_IN the_DT arctan_NN X_NNP 
          c_SYM /_NN R_NN and_CC is_VBZ expressed_VBN in_IN degrees_NNS ._.
        
        
          Calculation_NNP of_IN mean_NN melting_NN point_NN (_( MMP_NNP )_) of_IN red_JJ cell_NN
          membrane_NN phospholipid_NN
          The_DT MMP_NNP was_VBD determined_VBN by_IN as_IN described_VBN by_IN Jensen_NNP and_CC
          Patton_NNP [_NN 20_CD ]_NN ._. First_CD ,_, the_DT mol_NN %_NN of_IN each_DT fatty_NN acid_NN was_VBD
          calculated_VBN by_IN dividing_VBG the_DT mass_NN %_NN of_IN each_DT fatty_NN acid_NN by_IN
          its_PRP$ respective_JJ molecular_JJ weight_NN ._. Next_JJ ,_, we_PRP multiplied_VBN the_DT
          mol_NN %_NN by_IN the_DT (_( MP_NNP +_NN 100_CD )_) of_IN each_DT fatty_NN acid_NN to_TO obtain_VB the_DT
          melting_NN point_NN fractions_NNS ._. Finally_RB ,_, the_DT MP_NNP fractions_NNS were_VBD
          summed_VBD and_CC 100_CD was_VBD subtracted_VBN from_IN that_DT sum_NN to_TO provide_VB
          the_DT estimate_NN of_IN the_DT MMP_NNP of_IN the_DT acyl_NN chains_NNS of_IN the_DT
          phospholipid_NN preparation_NN ._. The_DT melting_VBG points_NNS used_VBN for_IN the_DT
          fatty_NN acids_NNS are_VBP as_IN follows_VBZ :_: C_NNP 14_CD :_: 0_CD (_( 54_CD °_NN C_NNP )_) ,_, C_NNP 15_CD :_: 0_CD (_( 52_CD °_NN C_NNP )_) ,_,
          C_NNP 16_CD :_: 0_CD (_( 63_CD °_NN C_NNP )_) ,_, C_NNP 16_CD :_: 1_CD (_( -_: 5_CD °_NN C_NNP )_) ,_, C_NNP 18_CD :_: 0_CD (_( 69_CD °_NN C_NNP )_) ,_, C_NNP 18_CD :_: 1_CD n-_NN 9_CD
          (_( 16_CD °_NN C_NNP )_) ,_, C_NNP 18_CD :_: 1_CD n-_NN 7_CD ,_, (_( 44_CD °_NN C_NNP )_) ,_, C_NNP 18_CD :_: 2_CD n-_NN 6_CD (_( -_: 5_CD °_NN C_NNP )_) ,_, C_NNP 18_CD :_: 3_CD n-_NN 6_CD
          (_( -_: 11_CD ._. 3_LS °_NN C_NNP )_) ,_, C_NNP 18_CD :_: 3_CD n-_NN 3_CD (_( -_: 10_CD °_NN C_NNP )_) ,_, C_NNP 20_CD :_: 4_CD n-_NN 6_CD (_( -_: 49_CD °_NN C_NNP )_) ,_, C_NNP 20_CD :_: 5_CD n-_NN 3_CD
          (_( -_: 54_CD °_NN C_NNP )_) ,_, C_NNP 22_CD :_: 5_CD n-_NN 3_CD (_( -_: 54_CD °_NN C_NNP )_) ,_, C_NNP 22_CD :_: 5_CD n-_NN 6_CD (_( -_: 44_CD ._. 1_LS °_NN C_NNP )_) ,_, C_NNP 22_CD :_: 6_CD n-_NN 3_CD
          (_( -_: 44_CD °_NN C_NNP )_) ._.
        
        
          Statistical_NNP analysis_NN
          Statistical_NNP analysis_NN was_VBD performed_VBN with_IN the_DT aid_NN of_IN
          NCSS_NNP statistical_JJ software_NN (_( NCSS_NNP ,_, Kaysville_NNP ,_, UT_NNP )_) ._. The_DT
          phospholipid_NN fatty_NN acid_NN proportions_NNS and_CC the_DT cholesterol_NN
          content_NN of_IN the_DT red_JJ cells_NNS of_IN SCD_NNP subjects_NNS and_CC controls_NNS
          were_VBD compared_VBN using_VBG a_DT two-sample_JJ t-test_JJ ._. Correlations_NNP of_IN
          the_DT various_JJ fatty_NN acid_NN percentages_NNS with_IN phase_NN angle_NN and_CC
          MMPs_NNP were_VBD estimated_VBN using_VBG regression_NN analysis_NN ._. A_DT p-value_JJ
          <_NN 0_CD ._. 05_CD was_VBD considered_VBN significant_JJ ._.
        
      
      
        Results_NNS
        
          Comments_NNS on_IN the_DT study_NN population_NN
          As_IN shown_VBN in_IN Table_NNP 1_CD ,_, the_DT mean_JJ age_NN of_IN the_DT male_JJ SCD_NNP
          subjects_NNS was_VBD not_RB significantly_RB different_JJ than_IN the_DT mean_JJ
          age_NN of_IN the_DT male_JJ controls_NNS ._. The_DT female_JJ SCD_NNP subjects_NNS were_VBD
          also_RB matched_VBN for_IN age_NN with_IN the_DT controls_NNS ._. No_DT significant_JJ
          differences_NNS in_IN any_DT of_IN the_DT body_NN composition_NN parameters_NNS
          such_JJ as_IN weight_NN ,_, height_NN ,_, %_NN FFM_NNP or_CC %_NN BF_NNP were_VBD observed_VBN between_IN
          either_DT the_DT male_JJ or_CC female_JJ subjects_NNS and_CC their_PRP$ respective_JJ
          controls_NNS ._. The_DT only_JJ exception_NN was_VBD the_DT phase_NN angle_NN for_IN
          which_WDT there_EX were_VBD significant_JJ differences_NNS between_IN controls_NNS
          and_CC SCD_NNP subjects_NNS for_IN both_DT males_NNS and_CC females_NNS (_( Table_NNP
          1_LS )_) ._.
        
        
          Fatty_NNP acid_NN profiles_NNS of_IN red_JJ cell_NN
          phospholipids_NNS
          Because_IN no_DT differences_NNS were_VBD found_VBN in_IN the_DT fatty_NN acid_NN
          proportions_NNS between_IN male_JJ and_CC female_JJ controls_NNS and_CC between_IN
          male_JJ and_CC female_JJ SCD_NNP subjects_NNS ,_, the_DT fatty_NN acid_NN data_NNS for_IN
          male_JJ and_CC female_JJ control_NN subjects_NNS were_VBD pooled_VBN and_CC the_DT data_NNS
          for_IN male_JJ and_CC female_JJ SCD_NNP subjects_NNS were_VBD combined_VBN ._. As_IN shown_VBN
          in_IN Table_NNP 2_CD ,_, the_DT red_JJ cell_NN phospholipids_NNS of_IN the_DT SCD_NNP
          subjects_NNS contained_VBD significantly_RB higher_JJR proportions_NNS of_IN
          the_DT two_CD major_NN saturated_VBD fatty_NN acids_NNS ,_, palmitic_JJ acid_NN
          (_( C_NNP 16_CD :_: 0_CD )_) and_CC stearic_JJ acid_NN (_( C_NNP 18_CD :_: 0_CD )_) ,_, than_IN the_DT controls_NNS ._. The_DT
          monounsaturated_JJ fatty_NN acids_NNS oleic_JJ acid_NN (_( 18_CD :_: 1_CD n-_NN 9_CD )_) and_CC
          vaccenic_JJ acid_NN (_( 18_CD :_: 1_CD n-_NN 7_CD )_) were_VBD also_RB significantly_RB elevated_VBD
          in_IN the_DT red_JJ cell_NN membrane_NN phospholipids_NNS of_IN the_DT SCD_NNP
          subjects_NNS ._.
          With_IN regard_NN to_TO the_DT n-_NN 6_CD family_NN of_IN polyunsaturated_JJ fatty_NN
          acids_NNS ,_, only_RB α_NN linoleic_JJ acid_NN (_( C_NNP 18_CD :_: 2_CD n-_NN 6_CD )_) and_CC arachidonic_JJ
          acid_NN (_( C_NNP 20_CD :_: 4_CD n-_NN 6_CD )_) were_VBD significantly_RB reduced_VBN in_IN the_DT
          membrane_NN phospholipids_NNS of_IN the_DT SCD_NNP subjects_NNS compared_VBN to_TO
          controls_NNS ._. For_IN the_DT n-_NN 3_CD family_NN of_IN polyunsaturated_JJ fatty_NN
          acids_NNS ,_, the_DT long_JJ chain_NN polyunsaturated_JJ fatty_NN acids_NNS derived_VBN
          from_IN α-linolenic_JJ acid_NN (_( C_NNP 18_CD :_: 3_CD n-_NN 3_LS )_) ,_, namely_RB eicosapentaenoic_JJ
          acid_NN (_( C_NNP 20_CD :_: 5_CD n-_NN 3_LS )_) and_CC docosahexaenoic_JJ acid_NN (_( C_NNP 22_CD :_: 6_CD n-_NN 3_LS )_) ,_, were_VBD
          significantly_RB reduced_VBN in_IN the_DT membrane_NN phospholipids_NNS of_IN
          the_DT SCD_NNP subjects_NNS ._. Overall_RB ,_, the_DT SCD_NNP subjects_NNS had_VBD increased_VBN
          proportions_NNS of_IN saturated_VBD fatty_NN acids_NNS in_IN their_PRP$ red_JJ cell_NN
          phospholipids_NNS and_CC significantly_RB decreased_VBD proportions_NNS of_IN
          polyunsaturated_JJ fatty_NN acids_NNS (_( Table_NNP 2_LS )_) ._.
        
        
          The_DT Mean_VB Melting_NNP Point_NNP (_( MMP_NNP )_) of_IN red_JJ cell_NN
          phospholipids_NNS
          The_DT finding_NN of_IN higher_JJR proportions_NNS of_IN the_DT high_JJ melting_NN
          saturated_VBN fatty_NN acids_NNS and_CC lesser_JJR amounts_NNS of_IN the_DT PUFA_NNP with_IN
          lower_JJR melting_VBG points_NNS in_IN the_DT red_JJ cell_NN phospholipids_NNS of_IN the_DT
          SCD_NNP subjects_NNS relative_JJ to_TO the_DT controls_NNS prompted_VBD us_PRP to_TO
          asses_NNS the_DT overall_JJ impact_NN of_IN these_DT differences_NNS on_IN the_DT
          relative_JJ fluidity_NN of_IN the_DT acyl_NN chains_NNS of_IN the_DT phospholipids_NNS
          from_IN the_DT red_JJ cells_NNS of_IN the_DT SCD_NNP patients_NNS and_CC the_DT controls_NNS
          by_IN estimating_VBG the_DT MMP_NNP of_IN the_DT phospholipids_NNS using_VBG the_DT
          approach_NN of_IN Jensen_NNP and_CC Patton_NNP [_NN 20_CD ]_NN ._. The_DT calculated_VBN MMP_NNP
          of_IN the_DT SCD_NNP subjects_NNS was_VBD significantly_RB higher_JJR than_IN for_IN the_DT
          controls_NNS ,_, 29_CD °_NN C_NNP vs_NNS 24_CD °_NN C_NNP ,_, p_NN <_NN 0_CD ._. 001_CD ._. The_DT estimated_VBN MMP_NNP
          of_IN the_DT red_JJ cell_NN phospholipids_NNS was_VBD also_RB inversely_RB
          correlated_JJ with_IN phase_NN angle_NN as_IN shown_VBN in_IN Figure_NN 1_CD (_( p_NN =_SYM
          0_CD ._. 001_CD )_) ._.
        
        
          Correlation_NNP of_IN phase_NN angle_NN with_IN individual_JJ
          phospholipid_NN fatty_NN acids_NNS and_CC cholesterol_NN
          Of_IN the_DT major_NN saturated_VBD fatty_NN acids_NNS that_WDT were_VBD found_VBN to_TO
          be_VB significantly_RB different_JJ between_IN the_DT phospholipids_NNS of_IN
          the_DT SCD_NNP patients_NNS and_CC controls_NNS ,_, only_RB palmitic_JJ acid_NN
          exhibited_VBN a_DT significant_JJ inverse_NN correlation_NN with_IN phase_NN
          angle_NN (_( p_NN =_SYM 0_CD ._. 03_CD )_) ._. A_DT negative_JJ correlation_NN with_IN phase_NN angle_NN
          was_VBD also_RB seen_VBN with_IN oleic_JJ acid_NN ,_, the_DT major_JJ monounsaturated_JJ
          fatty_NN acid_NN in_IN the_DT red_JJ cell_NN phospholipids_NNS (_( Fig_NNP ._. 2_LS ,_, p_NN <_NN
          0_CD ._. 001_CD ,_, )_) ._. Of_IN the_DT two_CD nutritionally_RB essential_JJ fatty_NN acids_NNS ,_,
          linoleic_JJ acid_NN (_( 18_CD :_: 2_CD n-_NN 6_CD )_) and_CC α-linolenic_JJ acid_NN (_( 18_CD :_: 3_CD n-_NN 3_LS )_) ,_,
          only_RB linoleic_JJ acid_NN was_VBD significantly_RB correlated_JJ with_IN
          phase_NN angle_NN (_( p_NN =_SYM 0_CD ._. 012_CD )_) ._.
          No_DT significant_JJ relations_NNS were_VBD found_VBN between_IN phase_NN
          angle_NN and_CC the_DT long-chain_JJ polyunsaturated_JJ fatty_NN acids_NNS of_IN
          the_DT n-_NN 6_CD series_NN ._. In_IN contrast_NN ,_, significant_JJ positive_JJ
          correlations_NNS were_VBD found_VBN between_IN the_DT phase_NN angle_NN and_CC the_DT
          following_VBG long-chain_JJ polyunsaturated_JJ fatty_NN acids_NNS of_IN the_DT
          n-_NN 3_CD series_NN and_CC which_WDT are_VBP derived_VBN from_IN α-linolenic_JJ acid_NN :_:
          eicosapentaenoic_JJ acid_NN ,_, 20_CD :_: 5_CD n-_NN 3_CD ,_, p_NN <_NN 0_CD ._. 001_CD ;_:
          docosapentaenoic_JJ acid_NN ,_, 22_CD :_: 5_CD n-_NN 3_CD ,_, p_NN <_NN 0_CD ._. 001_CD ;_: and_CC
          docosahexaenoic_JJ acid_NN ,_, 22_CD :_: 6_CD n-_NN 3_CD ,_, p_NN <_NN 0_CD ._. 001_CD ._. The_DT relation_NN
          between_IN phase_NN angle_NN and_CC docosahexaenoic_JJ acid_NN is_VBZ shown_VBN in_IN
          Figure_NN 3_CD ._. A_DT significant_JJ negative_JJ correlation_NN between_IN
          phase_NN angle_NN and_CC red_JJ cell_NN cholesterol_NN content_NN (_( expressed_VBD
          as_IN μg_NN cholesterol_NN /_NN μg_NN lipid_NN phosphorus_JJ )_) was_VBD also_RB
          obtained_VBN (_( Fig_NNP ._. 4_LS ,_, p_NN =_SYM 0_CD ._. 003_CD ,_, )_) ._.
          Fat-free_NNP mass_NN (_( FFM_NNP )_) ,_, the_DT major_JJ determinant_NN of_IN phase_NN
          angle_NN ,_, accounted_VBD for_IN 36_CD %_NN of_IN the_DT variation_NN in_IN phase_NN angle_NN
          in_IN our_PRP$ subjects_NNS ._. Therefore_RB ,_, the_DT statistical_JJ analyses_NNS were_VBD
          repeated_VBN including_VBG FFM_NNP in_IN the_DT regression_NN model_NN ._. When_WRB
          phase_NN angle_NN was_VBD the_DT dependent_JJ variable_JJ and_CC FFM_NNP ,_, oleic_JJ
          acid_NN ,_, 20_CD :_: 5_CD n-_NN 3_CD ,_, 22_CD :_: 5_CD n-_NN 3_CD ,_, and_CC DHA_NNP and_CC cholesterol_NN were_VBD
          included_VBN as_IN the_DT independent_JJ variables_NNS ,_, only_RB DHA_NNP and_CC FFM_NNP
          remained_VBD statistically_RB significant_JJ (_( p_NN =_SYM 0_CD ._. 004_CD ,_, p_NN <_NN
          0_CD ._. 001_CD ,_, respectively_RB )_) ._.
        
      
      
        Discussion_NNP
        The_DT results_NNS of_IN the_DT present_JJ study_NN confirm_VB our_PRP$ hypothesis_NNS ,_,
        based_VBN on_IN analyses_NNS of_IN serum_NN phospholipids_NNS conducted_VBN in_IN two_CD
        previous_JJ studies_NNS of_IN children_NNS with_IN SCD_NNP in_IN Nigeria_NNP [_NN 8_CD 21_CD ]_NN ,_,
        that_IN red_JJ cell_NN phospholipids_NNS of_IN children_NNS with_IN SCD_NNP contain_VB
        significantly_RB lower_JJR proportions_NNS of_IN n-_NN 3_CD polyunsaturated_JJ
        fatty_NN acids_NNS and_CC higher_JJR proportions_NNS of_IN saturated_VBD fatty_NN acids_NNS
        relative_JJ to_TO non-_NN SCD_NNP controls_NNS ._. These_DT results_NNS are_VBP in_IN
        agreement_NN with_IN those_DT of_IN Connor_NNP and_CC coworkers_NNS [_NN 22_CD ]_NN who_WP
        found_VBD similar_JJ alterations_NNS in_IN the_DT fatty_NN acid_NN composition_NN of_IN
        the_DT red_JJ cell_NN phospholipids_NNS of_IN U_NNP ._. S_NNP ._. children_NNS with_IN SCD_NNP ._. The_DT
        red_JJ cells_NNS of_IN the_DT SCD_NNP subjects_NNS in_IN the_DT present_JJ study_NN also_RB
        contained_VBD significantly_RB higher_JJR amounts_NNS of_IN cholesterol_NN ._. More_RBR
        importantly_RB ,_, in_IN the_DT present_JJ study_NN we_PRP found_VBD that_IN both_DT the_DT
        cholesterol_NN content_NN and_CC the_DT percentage_NN of_IN several_JJ n-_NN 3_CD fatty_NN
        acids_NNS in_IN the_DT red_JJ cells_NNS of_IN the_DT subjects_NNS were_VBD significantly_RB
        correlated_JJ with_IN phase_NN angle_NN ._. Overall_RB ,_, in_IN the_DT SCD_NNP children_NNS
        we_PRP studied_VBD ,_, cell_NN membrane_NN components_NNS that_WDT are_VBP known_VBN to_TO
        decrease_VB membrane_NN fluidity_NN ,_, such_JJ as_IN cholesterol_NN and_CC
        saturated_VBD fatty_NN acids_NNS ,_, were_VBD associated_VBN with_IN a_DT low_JJ phase_NN
        angle_NN while_IN those_DT which_WDT increase_VBP fluidity_NN ,_, such_JJ as_IN
        long-chain_JJ n-_NN 3_CD polyunsaturated_JJ fatty_NN acids_NNS ,_, were_VBD associated_VBN
        with_IN a_DT high_JJ phase_NN angle_NN ._.
        The_DT altered_VBN fatty_NN acid_NN composition_NN in_IN both_DT the_DT serum_NN and_CC
        red_JJ cell_NN phospholipids_NNS of_IN the_DT SCD_NNP subjects_NNS we_PRP studied_VBD may_MD
        be_VB due_JJ to_TO several_JJ causes_NNS ._. These_DT include_VBP :_: differences_NNS in_IN
        dietary_JJ intake_NN between_IN SCD_NNP patients_NNS and_CC controls_NNS ,_,
        aberrations_NNS of_IN the_DT desaturase-elongase_JJ pathway_NN that_IN
        interconverts_NNS n-_NN 3_CD and_CC n-_NN 6_CD polyunsaturated_JJ fatty_NN acids_NNS in_IN
        SCD_NNP ,_, and_CC increased_VBD metabolism_NN (_( e_SYM ._. g_SYM ._. ,_, β-oxidation_JJ )_) of_IN the_DT
        long-chain_JJ polyunsaturated_JJ fatty_NN acids_NNS in_IN SCD_NNP ._. Although_IN we_PRP
        did_VBD not_RB obtain_VB dietary_JJ information_NN for_IN the_DT subjects_NNS in_IN this_DT
        study_NN ,_, we_PRP assumed_VBD that_IN the_DT availability_NN of_IN foods_NNS containing_VBG
        the_DT essential_JJ and_CC long-chain_JJ fatty_NN acids_NNS did_VBD not_RB differ_VB
        between_IN SCD_NNP patients_NNS and_CC controls_NNS ._. However_RB ,_, the_DT SCD_NNP
        subjects_NNS may_MD have_VB been_VBN consuming_NN less_JJR food_NN ,_, on_IN average_JJ ,_,
        than_IN the_DT controls_NNS ._.
        With_IN regard_NN to_TO the_DT metabolism_NN of_IN fatty_NN acids_NNS mentioned_VBN
        above_IN ,_, the_DT activities_NNS of_IN the_DT enzymes_NNS that_WDT are_VBP responsible_JJ
        for_IN the_DT elongation_NN and_CC desaturation_NN of_IN the_DT essential_JJ fatty_NN
        acids_NNS to_TO produce_VB the_DT long-chain_JJ polyunsaturated_JJ fatty_NN acids_NNS
        may_MD vary_VB between_IN SCD_NNP subjects_NNS and_CC controls_NNS ._. In_IN a_DT study_NN of_IN
        children_NNS with_IN protein-energy_JJ malnutrition_NN ,_, Decsi_NNP and_CC
        coworkers_NNS [_NN 23_CD ]_NN used_VBD product_NN /_NN substrate_NN ratios_NNS of_IN fatty_NN
        acids_NNS in_IN serum_NN phospholipids_NNS to_TO speculate_VB that_IN children_NNS
        with_IN protein-energy_JJ malnutrition_NN have_VBP a_DT reduced_VBN level_NN of_IN
        Δ_NN 5_CD -_: desaturase_NN activity_NN compared_VBN to_TO well-nourished_JJ children_NNS ._.
        This_DT particular_JJ desaturase_NN is_VBZ a_DT regulatory_JJ enzyme_NN in_IN the_DT
        pathway_NN responsible_JJ for_IN the_DT biosynthesis_NNS of_IN long-chain_JJ
        polyunsaturated_JJ fatty_NN acids_NNS in_IN both_DT the_DT n-_NN 6_CD and_CC n-_NN 3_CD fatty_NN
        acid_NN families_NNS [_NN 24_CD ]_NN ._. Since_IN children_NNS with_IN SCD_NNP exhibit_NN some_DT
        of_IN the_DT characteristics_NNS of_IN malnutrition_NN ,_, such_JJ as_IN lower_JJR
        weight-for-age_JJ and_CC lower_JJR lean_JJ body_NN mass_NN ,_, the_DT activity_NN of_IN
        the_DT )_) 5_CD -_: desaturase_NN in_IN these_DT children_NNS may_MD be_VB decreased_VBN ,_,
        resulting_VBG in_IN lower_JJR proportions_NNS of_IN the_DT long-chain_JJ
        polyunsaturated_JJ fatty_NN acids_NNS in_IN both_DT serum_NN and_CC membrane_NN
        phospholipids_NNS ._.
        Two_CD important_JJ determinants_NNS of_IN membrane_NN fluidity_NN are_VBP the_DT
        cholesterol_NN content_NN and_CC the_DT proportions_NNS of_IN the_DT fatty_NN acids_NNS
        that_WDT comprise_VBP the_DT phospholipids_NNS of_IN membranes_NNS ._. One_CD way_NN to_TO
        compare_VB the_DT fluidity_NN of_IN membranes_NNS between_IN two_CD or_CC more_JJR
        populations_NNS is_VBZ to_TO determine_VB the_DT mean_NN melting_NN point_NN (_( MMP_NNP )_) of_IN
        the_DT fatty_NN acids_NNS in_IN the_DT total_JJ phospholipid_NN fraction_NN of_IN the_DT
        membrane_NN ._. For_IN such_JJ a_DT purpose_NN ,_, we_PRP used_VBD the_DT method_NN of_IN Jensen_NNP
        and_CC Patton_NNP [_NN 20_CD ]_NN to_TO estimate_VB the_DT MMP_NNP of_IN red_JJ cell_NN
        phospholipids_NNS ._. We_PRP found_VBD that_IN the_DT MMP_NNP of_IN the_DT membrane_NN
        phospholipids_NNS of_IN the_DT children_NNS with_IN SCD_NNP was_VBD significantly_RB
        higher_JJR compared_VBN to_TO controls_NNS ,_, indicating_VBG a_DT decrease_NN in_IN
        membrane_NN fluidity_NN in_IN the_DT SCD_NNP subjects_NNS ._. A_DT negative_JJ
        correlation_NN was_VBD also_RB observed_VBN between_IN MMP_NNP and_CC phase_NN angle_NN ._.
        This_DT observation_NN suggests_VBZ that_IN the_DT chemical_NN composition_NN and_CC
        properties_NNS of_IN tissue_NN membranes_NNS ,_, specifically_RB the_DT acyl_NN
        chains_NNS of_IN the_DT membrane_NN phospholipids_NNS ,_, directly_RB influence_NN
        the_DT magnitude_NN of_IN the_DT phase_NN angle_NN of_IN an_DT individual_NN ._.
        When_WRB we_PRP examined_VBD the_DT relation_NN between_IN phase_NN angle_NN and_CC
        red_JJ cell_NN cholesterol_NN ,_, a_DT significant_JJ negative_JJ correlation_NN
        was_VBD obtained_VBN between_IN phase_NN angle_NN and_CC red_JJ cell_NN cholesterol_NN
        for_IN the_DT total_JJ pool_NN of_IN subjects_NNS (_( SCD_NNP patients_NNS plus_CC controls_NNS )_)
        (_( p_NN =_SYM 0_CD ._. 003_CD )_) ._. However_RB ,_, when_WRB regression_NN models_NNS were_VBD used_VBN that_WDT
        included_JJ cholesterol_NN ,_, DHA_NNP ,_, and_CC FFM_NNP ,_, only_RB DHA_NNP and_CC FFM_NNP were_VBD
        found_VBN to_TO be_VB significantly_RB correlated_JJ with_IN phase_NN angle_NN ._.
        The_DT implications_NNS of_IN the_DT observed_VBN alterations_NNS in_IN the_DT
        membrane_NN lipids_NNS of_IN children_NNS with_IN SCD_NNP are_VBP not_RB known_VBN ;_:
        however_RB ,_, by_IN affecting_VBG the_DT physical_JJ properties_NNS of_IN tissue_NN
        membranes_NNS ,_, including_VBG fluidity_NN and_CC capacitance_NN ,_, these_DT
        changes_NNS could_MD compromise_VB various_JJ membrane_NN functions_NNS ._. In_IN an_DT 
        in_IN vitro_NN study_NN using_VBG red_JJ cells_NNS from_IN
        both_DT healthy_JJ subjects_NNS and_CC patients_NNS with_IN SCD_NNP ,_, Kuypers_NNP and_CC
        coworkers_NNS [_NN 25_CD ]_NN showed_VBD that_IN the_DT deformability_NN and_CC
        stability_NN of_IN SCD_NNP red_JJ cells_NNS could_MD be_VB altered_VBN by_IN changing_VBG the_DT
        fatty_NN acid_NN composition_NN of_IN the_DT phosphatidylcholine_NN (_( PC_NN )_)
        molecules_NNS of_IN the_DT membrane_NN ._. For_IN example_NN ,_, when_WRB they_PRP replaced_VBD
        the_DT native_JJ PC_NN with_IN 1_CD -_: palmitoyl_NN ,_, 2_CD -_: arachidonoyl-_NN PC_NN in_IN normal_JJ
        cells_NNS ,_, the_DT cells_NNS exhibited_VBN decreased_VBD osmotic_JJ fragility_NN
        without_IN a_DT change_NN in_IN hydration_NN ._. However_RB ,_, replacement_NN of_IN
        native_JJ PC_NN with_IN 1_CD ,_, 2_CD -_: dipalmitoyl-_NN PC_NN resulted_VBD in_IN an_DT increase_NN
        in_IN both_DT osmotic_JJ fragility_NN and_CC cellular_JJ hydration_NN ._. In_IN
        contrast_NN ,_, replacement_NN of_IN the_DT native_JJ PC_NN of_IN sickle_NN cells_NNS with_IN
        either_DT 1_CD -_: palmitoyl_NN ,_, -_: 2_CD arachidonyl_NN PC_NN ,_, 1_CD ,_, 2_CD -_: dipalmitoyl_NN PC_NN ,_, or_CC
        1_CD -_: palmitoyl_NN ,_, 2_CD -_: oleoyl_NN PC_NN led_VBN to_TO increased_VB cellular_JJ
        hydration_NN ._. The_DT authors_NNS concluded_VBD that_IN the_DT state_NN of_IN cellular_JJ
        hydration_NN of_IN sickle_NN cells_NNS may_MD be_VB modulated_JJ by_IN altering_VBG the_DT
        molecular_JJ species_NNS composition_NN of_IN the_DT membrane_NN 's_POS
        phospholipids_NNS ._. In_IN a_DT study_NN of_IN subjects_NNS with_IN type_NN 2_CD diabetes_NN ,_,
        Borkman_NNP and_CC coworkers_NNS [_NN 26_CD ]_NN found_VBD that_WDT decreased_VBD insulin_NN
        sensitivity_NN was_VBD associated_VBN with_IN a_DT decrease_NN in_IN the_DT
        proportions_NNS of_IN polyunsaturated_JJ fatty_NN acids_NNS in_IN
        skeletal-muscle_JJ phospholipids_NNS ._. They_PRP speculated_VBD that_IN changes_NNS
        in_IN the_DT fatty_NN acid_NN composition_NN of_IN muscle_NN membranes_NNS could_MD
        affect_VB insulin_NN sensitivity_NN ._.
        We_PRP reported_VBD previously_RB significantly_RB lower_JJR phase_NN angle_NN
        values_NNS in_IN both_DT African_NNP American_NNP and_CC Nigerian_NNP children_NNS with_IN
        SCD_NNP [_NN 18_CD 27_CD ]_NN ._. Because_IN phase_NN angle_NN is_VBZ related_VBN to_TO the_DT
        amount_NN of_IN lean_JJ body_NN tissue_NN and_CC the_DT corresponding_JJ amounts_NNS of_IN
        tissue_NN membranes_NNS [_NN 28_CD ]_NN ,_, it_PRP could_MD be_VB that_IN the_DT lower_JJR phase_NN
        angle_NN we_PRP observed_VBD previously_RB in_IN both_DT the_DT Nigerian_NNP and_CC
        African_NNP American_JJ children_NNS were_VBD the_DT result_NN of_IN the_DT lower_JJR FFM_NNP
        of_IN SCD_NNP children_NNS compared_VBN to_TO their_PRP$ corresponding_JJ controls_NNS ._.
        Patients_NNS with_IN SCD_NNP ,_, particularly_RB males_NNS over_IN the_DT age_NN of_IN 10_CD
        years_NNS ,_, usually_RB have_VBP significantly_RB less_JJR FFM_NNP than_IN their_PRP$
        healthy_JJ counterparts_NNS [_NN 29_CD ]_NN ._. However_RB ,_, in_IN the_DT present_JJ
        study_NN ,_, although_IN there_EX were_VBD no_DT significant_JJ differences_NNS in_IN
        the_DT mean_JJ weight_NN ,_, BMI_NNP ,_, or_CC FFM_NNP of_IN the_DT controls_NNS and_CC the_DT SCD_NNP
        subjects_NNS ,_, nevertheless_RB ,_, we_PRP still_RB observed_VBD a_DT statistically_RB
        significant_JJ difference_NN in_IN the_DT calculated_VBN phase_NN angle_NN of_IN the_DT
        two_CD groups_NNS ._. We_PRP suggest_VBP ,_, therefore_RB ,_, that_WDT factors_NNS other_JJ than_IN
        FFM_NNP and_CC which_WDT are_VBP not_RB related_VBN to_TO body_NN size_NN ,_, such_JJ as_IN the_DT
        lipid_NN composition_NN of_IN cell_NN membranes_NNS ,_, can_MD influence_VB the_DT
        phase_NN angle_NN of_IN individuals_NNS ._.
        It_PRP is_VBZ reasonable_JJ to_TO ask_VB whether_IN dietary_JJ modification_NN or_CC
        fatty_NN acid_NN supplementation_NN might_MD change_VB the_DT fatty_NN acid_NN
        composition_NN of_IN tissue_NN phospholipids_NNS in_IN children_NNS with_IN SCD_NNP ._.
        In_IN two_CD separate_JJ supplementation_NN studies_NNS involving_VBG SCD_NNP
        subjects_NNS ,_, changes_NNS in_IN the_DT fatty_NN acid_NN composition_NN of_IN red_JJ cell_NN
        phospholipids_NNS were_VBD obtained_VBN after_IN supplementation_NN with_IN fish_NN
        oil_NN containing_VBG high_JJ amounts_NNS of_IN long-chain_JJ polyunsaturated_JJ
        n-_NN 3_CD fatty_NN acids_NNS ._. In_IN the_DT first_JJ study_NN ,_, Muskeit_NNP and_CC coworkers_NNS
        [_NN 30_CD ]_NN supplemented_JJ 13_CD SCD_NNP patients_NNS for_IN 7_CD months_NNS with_IN
        capsules_NNS containing_VBG eicosapentaenoic_JJ acid_NN ,_, docosahexaenoic_JJ
        acid_NN and_CC vitamin_NN E_NNP ._. This_DT supplementation_NN regimen_NN resulted_VBD
        in_IN increased_VBN incorporation_NN of_IN n-_NN 3_CD fatty_NN acids_NNS in_IN both_DT
        plasma_NN cholesterylesters_NNS and_CC red_JJ blood_NN cells_NNS ._. The_DT
        double-bond_JJ index_NN of_IN the_DT red_JJ cells_NNS increased_VBN ,_, indicating_VBG an_DT
        increase_NN in_IN red_JJ cell_NN membrane_NN fluidity_NN and_CC deformability_NN ._.
        In_IN the_DT second_JJ study_NN ,_, Tomer_NNP and_CC coworkers_NNS [_NN 31_CD ]_NN also_RB
        demonstrated_VBD changes_NNS in_IN platelet_NN and_CC red_JJ cell_NN activation_NN
        markers_NNS in_IN subjects_NNS with_IN SCD_NNP following_VBG fish_NN oil_NN
        supplementation_NN for_IN one_CD year_NN ,_, resulting_VBG in_IN fewer_JJR pain_NN
        episodes_NNS compared_VBN to_TO subjects_NNS supplemented_JJ with_IN n-_NN 6_CD fatty_NN
        acids_NNS ._.
        In_IN summary_NN ,_, we_PRP have_VBP shown_VBN in_IN children_NNS with_IN SCD_NNP that_IN the_DT
        lipid_NN composition_NN of_IN their_PRP$ cellular_JJ membranes_NNS is_VBZ related_VBN to_TO
        phase_VB angle_NN ,_, a_DT non-invasive_JJ whole_JJ body_NN measurement_NN of_IN
        membrane_NN integrity_NN and_CC function_NN ._. Membrane_NNP function_NN is_VBZ
        altered_VBN in_IN a_DT variety_NN of_IN clinical_JJ conditions_NNS and_CC the_DT phase_NN
        angle_NN may_MD provide_VB a_DT rapid_JJ ,_, non-invasive_JJ means_NNS of_IN monitoring_VBG
        the_DT effect_NN of_IN therapies_NNS aimed_VBN at_IN improving_VBG the_DT health_NN of_IN
        individuals_NNS in_IN whom_WP cell_NN membrane_NN function_NN may_MD be_VB deranged_JJ ._.
        Although_IN it_PRP is_VBZ known_VBN that_DT supplementation_NN with_IN n-_NN 3_CD fatty_NN
        acids_NNS produces_VBZ changes_NNS in_IN the_DT membrane_NN composition_NN of_IN
        cells_NNS ,_, it_PRP has_VBZ yet_RB to_TO be_VB determined_VBN whether_IN phase_NN angle_NN can_MD
        be_VB used_VBN as_IN an_DT alternative_JJ approach_NN for_IN monitoring_VBG these_DT
        changes_NNS ._. Studies_NNS of_IN this_DT nature_NN are_VBP in_IN progress_NN ._.
      
      
        Abbreviations_NNP
        SCD_NNP ,_, sickle_NN cell_NN disease_NN ;_: R_NN ,_, resistance_NN ,_, Xc_NNP ,_, reactance_NN ;_:
        MMP_NNP ,_, mean_VB melting_NN point_NN ;_: FFM_NNP ,_, fat-free_JJ mass_NN ;_: BMI_NNP ,_, body_NN mass_NN
        index_NN ;_: DHA_NNP ,_, docosahexaenoic_JJ acid_NN ;_: PC_NN ,_,
        phosphatidylcholine_NN ._.
      
    
  
